Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2500258	注射用SHR-A1904	SHR-A1904	Lyophilized	Biological Products(1)	New Drug Application	2025-04-01		Suzhou Suncadia Biopharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd			view
CXSL2500156	注射用SHR-A1904	SHR-A1904	Lyophilized	Biological Products(1)	New Drug Application	2025-02-18		Suzhou Suncadia Biopharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd			view
CXSB2400076	注射用SHR-A1904	SHR-A1904	Lyophilized	Biological Products(1)	Supplementary Application	2024-07-17		Suzhou Suncadia Biopharmaceuticals Co Ltd;Shanghai Hengrui Pharmaceutical Co Ltd			view
CXSL2400040	注射用SHR-A1904	SHR-A1904	Lyophilized	Biological Products(1)	New Drug Application	2024-01-19		Shanghai Hengrui Pharmaceutical Co Ltd			view
CXSL2400027	注射用SHR-A1904	SHR-A1904	Lyophilized	Biological Products(1)	New Drug Application	2024-01-12		Shanghai Hengrui Pharmaceutical Co Ltd			view
CXSL2100034	注射用SHR-A1904	SHR-A1904	Lyophilized	Biological Products(1)	New Drug Application	2021-01-29	上海恒瑞医药有限公司	Shanghai Hengrui Pharmaceutical Co Ltd	In Review	2021-01-28	view